Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
RadioPharm Theranostics Logo
RadioPharm Theranostics Growth Score
57
CB Rank
58284
Heat Score
57
RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.
Founded
obfuscation
PublicPost-IPO Equity Carlton South, Victoria, Australia11-50 www.radiopharmtheranostics.com
Biotechnology
Consulting
Pharmaceutical
Therapeutics
Overview

RadioPharm Theranostics
Total Funding
obfuscation
Growth Score
57
Heat Score
57

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score57
-19 pts
in past quarter
Heat Score 57
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About RadioPharm Theranostics

CB Rank
58284
RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.
Founded
obfuscation
PublicPost-IPO Equity Carlton South, Victoria, Australia11-50 www.radiopharmtheranostics.com
Biotechnology
Consulting
Pharmaceutical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

  • Photo of Riccardo Canevari
    Riccardo Canevari: Managing Director and CEO
    Past Role: Advanced Accelerator Applications, Chief Commercial Officer
  • Photo of Paul Hopper
    Paul Hopper: Executive Chairman & Founder
    Past Role: Polynoma, Founder

Details

Legal Name Radiopharm Theranostics Limited
Operating Status Active
Stock Symbol  ASX:RAD
Company Type For Profit
Founders  Paul Hopper
About the Company
RadioPharm Theranostics develops radiopharmaceutical products for diagnostic and therapeutic uses. They apply the potential of radiopharmaceuticals in treating oncological diseases. Their radiopharmaceuticals are safe radioactive drugs for use as diagnostic and therapeutic tools.
Phone Number +61 3 9824 5254
Contact Email info@radiopharmaceuticals.com
Predictions & Insights

Growth Insight

See this Growth Insight
RadioPharm Theranostics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Nano-mAbs
A radiopharmaceutical platform using genetically engineered camelid-derived single domain antibodies labeled with a radioisotope for both therapeutic and diagnostic purposes, targeting HER-2, TROP-2, and PD-L1.
HER-2 Imaging
A diagnostic imaging product using Technetium-99m to detect HER-2 expression in breast cancer, providing detailed imaging of primary tumors and metastatic lesions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
1
obfuscation
Lantheus HoldingsPost-IPO Equity
obfuscation
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
1
obfuscation
Lantheus HoldingsPost-IPO Equity
obfuscation
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
1
obfuscation
Lantheus HoldingsPost-IPO Equity
obfuscation
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
1
obfuscation
Lantheus HoldingsPost-IPO Equity
obfuscation
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
1
obfuscation
Lantheus HoldingsPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
1
obfuscation
Lantheus HoldingsPost-IPO Equity
obfuscation
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
1
obfuscation
Lantheus HoldingsPost-IPO Equity
obfuscation
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
1
obfuscation
Lantheus HoldingsPost-IPO Equity
obfuscation
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
1
obfuscation
Lantheus HoldingsPost-IPO Equity
obfuscation
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
1
obfuscation
Lantheus HoldingsPost-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Board Members and Advisors 1 Contacts 3

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 16, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 8, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

3,518
65.24%
 in past month

Interest Signals

TopicSurge Score
Google (GOOG) Logo
Google (GOOG)
66

Active Website Tech Count

39RadioPharm Theranostics is actively using 39 technologies for its website, according to BuiltWith. These include Viewport Meta, SPF, and  SSL by Default.
Sub-Organizations
Frequently Asked Questions

Where is RadioPharm Theranostics's headquarters? RadioPharm Theranostics is located in Carlton South, Victoria, Australia.Who invested in RadioPharm Theranostics? RadioPharm Theranostics has 2 investors including Lantheus Holdings and  Lantheus Holdings.When was the last funding round for RadioPharm Theranostics? RadioPharm Theranostics closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has RadioPharm Theranostics raised to date? RadioPharm Theranostics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ee511ef 1)
|